| 21791641 |
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors
Zheng, W,
Lindeman, N,
Capelletti, M,
Gray, NS,
Wong, KK,
Christensen, JG,
Ercan, D,
Jänne, PA,
Rodig, SJ,
Shimamura, T,
Nikiforow, S,
Weremowicz, S,
Sasaki, T,
Okuda, K,
Wilner, K,
Eck, MJ,
Butaney, M,
Stumpfova, M,
Yanagita, M,
Heon, S,
Ogino, A,
Xiao, Y,
Marcoux, JP,
Koivunen, J,
Lathan, C,
Du, J
|
Cancer Res. |
2011 |
